(c) Cp 090104 and CP-derived BLPs improve the adaptive immune responses induced by pneumococcal vaccines and enhance resistance to secondary pneumococcal infection. Secondary respiratory bacterial infections following primary viral infections can lead to significant morbidity and mortality in young individuals [34,35,36]. The gene discussed is CP; the disease is pneumococcal infection.